Cushing's syndrome with concurrent use of fluvoxamine, budesonide
-
Published:2015-11-20
Issue:12
Volume:26
Page:2-3
-
ISSN:1068-5308
-
Container-title:The Brown University Psychopharmacology Update
-
language:en
-
Short-container-title:The Brown University Psychopharmacology Update
Author:
Lam Y. W. Francis
Reference2 articles.
1. Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver;Jonsson;Drug Metab Dispos,1995
2. Iatrogenic Cushing's syndrome related to the interaction between oral budesonide with fluvoxamine: A case report;Martin;J Clin Pharm Ther,2015